Year Established :
1988
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
more than 1000
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Our advantages:
1.We're china's biggest domestic tubular vial factory, and production capacity (vial+caps) is over 10 billion pcs per year
2. The best public main board listed company in china, and Stock code: 603976
3. Have 4 production bases, 5 branch factories, and 1800+ employees, 32 pcs innovative patents
4. Have a conformity assessment of the china committee approved by CNAS lab( registered No. CNAS L7694)
5. With YBB, ISO, EP, USP standards
6. Have USA FDA DMF files (DMF Number Assigned: 21564, 21565)
7. we're the first to do and pass ISO15378 and ISO9001 Quality management system certification
8. Have cooperated with ASTRAZENECA(UK), China National Pharmaceutical Group Corporation (SINO Pharma), Guangzhou Pharmaceutical Holdings Limited.
Patents and Copyrights :
31 patents
Business Type :
Distributor,Trading Company,Service Provider,Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Annual Turnover(USD) :
More than 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
neutral borosilicate glass vials, injection vials, low borosilicate glass bottle
ampoules, prefiled syringe and middle borosilicate glass tube